Clinical consequences of profound anemia.

M. Devagiri,P. Ford
DOI: https://doi.org/10.1200/JCO.2009.27.15_SUPPL.E20666
IF: 45.3
2009-05-20
Journal of Clinical Oncology
Abstract:e20666 Background: Although there is an emerging trend to reduce blood transfusions, there is still very little randomized data outside of the critical care setting that identifies the risks and benefits of transfusion support. Many clinicians base the decision to transfuse primarily on the hemoglobin (Hb) level independent of symptoms. Little is known about the clinical consequences of profound anemia although there is concern that withholding transfusion will result in adverse outcomes in those with advanced age or underlying cardiovascular conditions. METHODS A retrospective chart review of 32 patients declining blood transfusions from January 2004 to June 2008 was performed to evaluate the clinical consequences of anemia. This population included a broad range of medical, surgical and obstetrical cases and their ages ranged from 84 to 28yrs (mean 53.03). The initial Hb ranged from 3.2 to 6.8 (mean 5.04).12 patients had Hb levels less than 4.9 and 3 patients had levels less than 4. Our non blood approach included simultaneous interventions to stimulate erythropoiesis, control bleeding, enhance hemostasis, minimize blood loss and maintain hemodynamic stability. RESULTS 6/32 patients (18.75%) had cardiac complications related to anemia like congestive heart failure, myocardial ischemia, and cardiac arrest. They occurred predominantly in patients with underlying cardiovascular disease (4/7) with increased tendency in patients with structural heart disease like Hypertrophic Obstructive Cardiomyopathy (HOCM) and critical Aortic stenosis (3/3) at Hb levels of 4.8 and 5.6. Patients without any pre-existing cardiovascular illness tolerated very low levels of Hb of 2.5 and 4 before they had cardiac arrest from anemia. 2 patients above the age of 70 tolerated the Hb levels of 2.7 and 3.3 without complications. 2 of 3 patients with Hb less than 3 had no complications.4 deaths are noted. CONCLUSIONS This study illustrates that patients without cardiovascular co-morbidity tolerate levels of Hb as low as 3.3 without significant events. However patients with structural heart disease like Aortic stenosis and HOCM have shown the signs of decompensation at a lower degree of anemia which suggests that they need transfusion at lower degree of anemia. No significant financial relationships to disclose.
What problem does this paper attempt to address?